Skip to main content
Log in

Aspirin has “favourable” cost utility in older women

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. Pignone M, Earnshaw S, Pletcher MJ, Tice JA.Aspirin for the primary prevention of cardiovascular disease in women: a cost-utility analysis. Archives of Internal Medicine 167: 290-295, No. 3, 12 Feb 2007

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Aspirin has “favourable” cost utility in older women. Pharmacoecon. Outcomes News 525, 4 (2007). https://doi.org/10.2165/00151234-200705250-00012

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200705250-00012

Keywords

Navigation